Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 131 - 140 of 243
Alternative Name: MENT Transdermal Gel
Active Status: No
User: Male
Mode: Yes
Delivery Type: Transdermal
Developer: Population Council
Project Stage: Phase I
Alternative Name: MENT Acetate Implant, 7α-methyl-19-nortestosterone
Active Status: Yes
User: Male
Mode: Yes
Delivery Type: Subdermal
Developer: Population Council
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Merck
Project Stage: Prototype Development
Alternative Name: Metalloprotease
Target
Active Status: Yes
User: Female
Mode: No
Developer: Oregon Health & Science University
Role in reproduction: Oocyte Maturation
Project Stage: Target Validation
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: 7Med Industrie, France
Project Stage: Regulatory
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: 7Med Industrie, France
Project Stage: Regulatory
Alternative Name: MAP, Microneedle Patch
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Other
Developer: PATH, Queen's University Belfast, ViiV Healthcare, Population Council, LTS Lohmann Therapie-Systeme AG
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Microchips Biotech, Inc.
Project Stage: Prototype Development
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: FHI 360, University of Washington
Project Stage: Pre-clinical
Alternative Name: MZCL Combination IVR
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Vaginal Ring
Developer: Population Council, ProMed Pharma
Project Stage: Pre-clinical

Pages

CSV